Brain dopamine and behaviour. A critical analysis of the relationship between dopamine antagonism and therapeutic efficacy of neuroleptic drugs.
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001143:Arousal / Q000187:drug effects; D001921:Brain / Q000378:metabolism*; D002746:Chlorpromazine / Q000494:pharmacology; D003342:Corpus Striatum / Q000187:drug effects; D004298:Dopamine / Q000378:metabolism; D018492:Dopamine Antagonists; D006801:Humans; D008636:Mesencephalon / Q000378:metabolism; D009043:Motor Activity / Q000187:drug effects; D009949:Orientation / Q000187:drug effects; D051381:Rats; D011955:Receptors, Drug; D012201:Reward; D012559:Schizophrenia / Q000188:drug therapy* / Q000378:metabolism; D013881:Thioridazine / Q000494:pharmacology; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D018492:Dopamine Antagonists; D011955:Receptors, Drug; D014149:Tranquilizing Agents; D000661:Amphetamine; D013881:Thioridazine; D002746:Chlorpromazine; D004298:Dopamine